Table 2. Cisplatin nephrotoxicity in user or non-user of DPP-4 inhibitors.

Characteristics	DPP-4 inhibitor group	non-DPP-4 inhibitor group	P value
% decline of eGFR; mean (SD)	23.6 (20.3)	43.1 (20.1)	0.010
AKI incidence; number (%)	5 (25)	9 (64)	0.026
AKI Stage; number
1	2	5	0.043
2	2	2	0.328
3	1	2	0.210

Abbreviations: eGFR, estimated glomerular filtration rate. AKI, acute kidney injury.